Xiangxue Pharmaceutical Co.,Ltd. (300147.SZ)

CNY 12.14

(2.53%)

Annual Balance Sheets

(In CNY)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 8.28 Billion 9.35 Billion 11.38 Billion 9.77 Billion 8.46 Billion 8.62 Billion
Total Current Assets 1.82 Billion 1.69 Billion 3.08 Billion 3.72 Billion 3.09 Billion 3.91 Billion
Cash And Short Term Investments 149.31 Million 166.62 Million 261.74 Million 624.47 Million 524.23 Million 673.44 Million
Cash and Cash Equivalents 149.31 Million 166.5 Million 196.12 Million 605.13 Million 495.69 Million 650.1 Million
Short Term Investments -40.87 Million 125.98 Thousand 65.62 Million 19.33 Million 28.54 Million 23.33 Million
Net Receivables 1.19 Billion 971.29 Million 1.84 Billion 2.14 Billion 1.74 Billion 2.09 Billion
Inventory 411.29 Million 467.07 Million 761.46 Million 839.8 Million 756.4 Million 590.06 Million
Other Current Assets 68.45 Million 88.18 Million 221.36 Million 108.99 Million 70.9 Million 559.73 Million
Total Non-Current Assets 6.45 Billion 7.65 Billion 8.29 Billion 6.05 Billion 5.36 Billion 4.7 Billion
Net PPE 4.61 Billion 5.52 Billion 5.95 Billion 3.48 Billion 3.29 Billion 2.68 Billion
Good Will And Intangible Assets 1.55 Billion 1.56 Billion 1.69 Billion 1.6 Billion 1.34 Billion 1.42 Billion
Good Will 199.72 Million 199.72 Million 266.59 Million 626.61 Million 626.61 Million 644.66 Million
Intangible Assets 1.35 Billion 1.36 Billion 1.42 Billion 973.96 Million 721.62 Million 778.35 Million
Long-Term Investments 219.35 Million 471.9 Million 204.58 Million 423.66 Million 412.48 Million 342.85 Million
Tax Assets 28.41 Million 26.3 Million 19.37 Million 21.22 Million 39.78 Million 31.44 Million
Other Non Current Assets 33.07 Million 69.37 Million 418.48 Million 523.28 Million 268.2 Million 226.71 Million
Other Assets - - - 1.00 1.00 1.00
Total Liabilities 5.96 Billion 6.53 Billion 7.62 Billion 5.52 Billion 4.35 Billion 4.61 Billion
Total Current Liabilities 5.16 Billion 5.85 Billion 6.94 Billion 4.38 Billion 3.26 Billion 3.22 Billion
Account Payables 1.08 Billion 841.31 Million 1.12 Billion 801 Million 707.72 Million 451.43 Million
Tax Payables 70.62 Million 33.59 Million 31.94 Million 33.8 Million 35.03 Million 23.26 Million
Short Term Debt 1.84 Billion 2 Billion 2.91 Billion 3.01 Billion 1.74 Billion 2.31 Billion
Deferred Revenue 2.16 Billion 249.78 Million 2.88 Billion 553.85 Million 745.21 Million 23.26 Million
Other Current Liabilities 67.24 Million 2.75 Billion 15.28 Million 9.83 Million 66.11 Million 431.73 Million
Total Non Current Liabilities 805.73 Million 682.26 Million 678.51 Million 1.14 Billion 1.08 Billion 1.39 Billion
Long-Term Debt 590.91 Million 451.85 Million 531.28 Million 946.91 Million 938.2 Million 1.3 Billion
Deferred Revenue Non Current 60.42 Million 60.35 Million 65.64 Million 75.66 Million 85.97 Million 58.55 Million
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 144.92 Million 170.06 Million 77.85 Million 122.5 Million 938.2 Million 9.4 Million
Other Liabilities 1.00 - 1.00 1.00 1.00 -
Total Equity 2.31 Billion 2.81 Billion 3.75 Billion 4.25 Billion 4.11 Billion 4.01 Billion
Stock Holders Equity 1.92 Billion 2.4 Billion 2.94 Billion 3.61 Billion 3.48 Billion 3.43 Billion
Common Stock 661.27 Million 661.27 Million 661.36 Million 661.47 Million 661.47 Million 661.47 Million
Retained Earnings -987.43 Million -500.11 Million 33.04 Million 720.36 Million 699.95 Million 610.42 Million
Accumulated other comprehensive income 1.69 Million 100.52 Million 116.82 Million 109.92 Million 65.09 Million 91.73 Million
Common Stock Equity 1.92 Billion 2.4 Billion 2.94 Billion 3.61 Billion 3.48 Billion 3.43 Billion
Capital Lease Obligation 34.91 Million 24.91 Million 2.35 Million 2.32 Million - -
Total Investments 178.47 Million 472.02 Million 270.21 Million 443 Million 441.02 Million 366.19 Million
Total Debt 2.43 Billion 2.45 Billion 3.44 Billion 3.96 Billion 2.68 Billion 3.62 Billion
Net Debt 2.28 Billion 2.29 Billion 3.25 Billion 3.35 Billion 2.18 Billion 2.97 Billion

Balance Sheet Charts